Serine protease inhibitory effects of health supplements in human cancerous cell lines
OwnerTeerapol SRICHANA, Kumar Bijon SIL +1inventors
InventorsTeerapol SRICHANA, Kumar Bijon SIL, Kumar Pijush PAUL
Life of this patent
Estimating the term…
Loading patent…
OwnerTeerapol SRICHANA, Kumar Bijon SIL +1inventors
InventorsTeerapol SRICHANA, Kumar Bijon SIL, Kumar Pijush PAUL
Estimating the term…
The present invention relates generally to a method of detecting inhibitory effects of health supplements on serine protease in cell lines derived from human carcinomas. More, particularly, the present invention relates to inhibitory analysis of health supplementary products taken from market and/or chemically purified forms, in order to determine their competitors and/or inhibitory effects on serine protease such as trypsin so that these supplements can be used for the treatment once someone develop intense inflammatory reactions either due to infections like COVID-19 and/or pathological conditions such as cancer. The present invention further provides therapeutic applications for agents and/or condition which utilize human enzymatic system and/or cellular components for the development of pathological conditions.
A serine protease inhibitor consisting of a combined formulation of health supplements selected from the group consisting of chemically purified ascorbic acid, thiamine and pyridoxine.
A process for preparing a serine protease inhibitor, consisting of a multiple chemically pure FDA approved health supplements commonly available in market, said serine proteases inhibitor inhibiting the protease activity of at least one serine protease in cell culture system is comprising
Dependencies are inferred from the claim text.